Why Agile Therapeutics (AGRX) Stock Is Down 60%
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Agile Therapeutics Inc (OTC:AGRX) shares are trading lower by 61% to $0.24 during Tuesday's session after the company announced the suspension of its trading on the Nasdaq effective Tuesday. The company received a final delisting notice from Nasdaq due to its failure to meet the minimum stockholders' equity requirement.
Agile Therapeutics Inc（场外交易代码：AGRX）宣布从周二起暂停在纳斯达克的交易后，该公司股价在周二的交易中下跌了61％，至0.24美元。由于未能满足最低股东权益要求，该公司收到了纳斯达克的最终退市通知。
As a result, trading of its common stock on Nasdaq was suspended effective March 26. However, the company's shares will still be publicly traded on the over-the-counter market operated by the OTC Markets Group Inc. under the symbol AGRX.
结果，其在纳斯达克的普通股自3月26日起暂停交易。但是，该公司的股票仍将在场外市场集团公司运营的场外交易市场上公开交易，股票代码为AGRX。
Agile Therapeutics added and emphasized that this transition will not impact its business operations and reaffirms its commitment to executing its business plan and exploring strategic opportunities to enhance Twirla growth and shareholder value.
Agile Therapeutics补充说，此次过渡不会影响其业务运营，并重申了其执行业务计划和探索战略机会以提高Twirla增长和股东价值的承诺。
According to data from Benzinga Pro, AGRX has a 52-week high of $12.25 and a 52-week low of $0.20.
根据Benzinga Pro的数据，AGRX的52周高点为12.25美元，52周低点为0.20美元。